Literature DB >> 365205

Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations.

R G Gibson, S L Gibson, A D MacNeill, G H Gray, W C Dick, W W Buchanan.   

Abstract

This paper reports the results of a pilot study in which 41 patients with rheumatoid arthritis were treated with high doses of salicylate, 3.9 g per day, and the results compared with a further 54 similar patients treated with homoeopathy. Both groups were compared with 100 patients who received placebo. 2 The patients who received homoeopathy did better than those who received salicylate. The design of the trial was such, however, that it was not possible to distinguish between the effects due to the physicians and the effects due to the drugs and a further trial is planned to elucidate this point. 3 Patients on homoeopathic treatment did not experience toxic effects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365205      PMCID: PMC1429555          DOI: 10.1111/j.1365-2125.1978.tb04602.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis.

Authors:  P Lee; J A Anderson; J Miller; J Webb; W W Buchanan
Journal:  J Rheumatol       Date:  1976-09       Impact factor: 4.666

2.  How safe are anti-rheumatic drugs? A study of possible iatrogenic deaths in patients with rheumatoid arthritis.

Authors:  P M Brooks; W H Stephens; M E Stephens; W W Buchanan
Journal:  Health Bull (Edinb)       Date:  1975-05

3.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

4.  Rapid determination of salicylate in biological fluids.

Authors:  P TRINDER
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

5.  Control of post-pneumoencephalographic headaches with EC 112; a preliminary review.

Authors:  L B MANN; A B WEBER
Journal:  Bull Los Angel Neuro Soc       Date:  1953-03

6.  Graphic representation of pain.

Authors:  J Scott; E C Huskisson
Journal:  Pain       Date:  1976-06       Impact factor: 6.961

7.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

8.  Death after taking medicaments.

Authors:  R H Girdwood
Journal:  Br Med J       Date:  1974-03-16

9.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

10.  Evaluation of digital joint circumference measurements in rheumatoid arthritis.

Authors:  J Webb; W W Downie; W C Dick; P Lee
Journal:  Scand J Rheumatol       Date:  1973       Impact factor: 3.641

View more
  7 in total

Review 1.  Is homoeopathy a placebo?

Authors:  E Ernst
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  [Not Available].

Authors:  P Lépine
Journal:  Can Fam Physician       Date:  1990-01       Impact factor: 3.275

3.  Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial.

Authors:  R G Gibson; S L Gibson; A D MacNeill; W W Buchanan
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

4.  Salicylates and homeopathy.

Authors:  G Huston
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

5.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

6.  Clinical trials of homoeopathy.

Authors:  J Kleijnen; P Knipschild; G ter Riet
Journal:  BMJ       Date:  1991-02-09

7.  Levels of Health Theory With the Example of a Case of Juvenile Rheumatoid Arthritis.

Authors:  Dmitri Chabanov; Dionysis Tsintzas; George Vithoulkas
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.